Add to ORKGTreatment of resistant metastatic melanoma using sequential epigenetic therapy (decitabine and panobinostat) combined with chemotherapy (temozolomide
Melanoma is the most aggressive form of skin cancer and, if spread outside the epidermis, has a dism...
© 2018 Dr Shatha AbuHammadActivation of the Cyclin-Dependent Kinase 4 (CDK4) pathway is a frequent o...
Abstract: The treatment of melanoma has been revolutionized by new therapies targeting MAPK signalin...
Melanoma is rapidly increasing in incidence throughout the world. Early stages are curable with surg...
Decitabine, an epigenetic modifier that reactivates genes otherwise suppressed by DNA promoter methy...
Decitabine, an epigenetic modifier that reactivates genes otherwise suppressed by DNA promoter methy...
Abstract: Resistance to chemotherapy, biological and targeted therapies is an important clinical pro...
Cancer drug resistance is an enormous problem. It is responsible for most relapses in cancer patient...
The lack of second-line treatment for relapsed ovarian cancer necessitates the development of improv...
Apoptosis genes, such as TP53 and p16/CDKN2A, that mediate responses to cytotoxic chemotherapy, are ...
Metastatic melanoma has long been considered to have a very poor prognosis and to be chemo-resistant...
Melanoma is the deadliest form of skin cancer. The disease is driven by molecular alterations in onc...
The efficacy of platinum-based chemotherapy for immune checkpoint inhibitor-resistant advanced melan...
Melanoma is an aggressive skin cancer reliant on early detection for high likelihood of successful t...
Cutaneous melanoma is a lethal disease, even when diagnosed in advanced stages. Although recent prog...
Melanoma is the most aggressive form of skin cancer and, if spread outside the epidermis, has a dism...
© 2018 Dr Shatha AbuHammadActivation of the Cyclin-Dependent Kinase 4 (CDK4) pathway is a frequent o...
Abstract: The treatment of melanoma has been revolutionized by new therapies targeting MAPK signalin...
Melanoma is rapidly increasing in incidence throughout the world. Early stages are curable with surg...
Decitabine, an epigenetic modifier that reactivates genes otherwise suppressed by DNA promoter methy...
Decitabine, an epigenetic modifier that reactivates genes otherwise suppressed by DNA promoter methy...
Abstract: Resistance to chemotherapy, biological and targeted therapies is an important clinical pro...
Cancer drug resistance is an enormous problem. It is responsible for most relapses in cancer patient...
The lack of second-line treatment for relapsed ovarian cancer necessitates the development of improv...
Apoptosis genes, such as TP53 and p16/CDKN2A, that mediate responses to cytotoxic chemotherapy, are ...
Metastatic melanoma has long been considered to have a very poor prognosis and to be chemo-resistant...
Melanoma is the deadliest form of skin cancer. The disease is driven by molecular alterations in onc...
The efficacy of platinum-based chemotherapy for immune checkpoint inhibitor-resistant advanced melan...
Melanoma is an aggressive skin cancer reliant on early detection for high likelihood of successful t...
Cutaneous melanoma is a lethal disease, even when diagnosed in advanced stages. Although recent prog...
Melanoma is the most aggressive form of skin cancer and, if spread outside the epidermis, has a dism...
© 2018 Dr Shatha AbuHammadActivation of the Cyclin-Dependent Kinase 4 (CDK4) pathway is a frequent o...
Abstract: The treatment of melanoma has been revolutionized by new therapies targeting MAPK signalin...